Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants ; volume:8 ; number:1 ; day:20 ; month:11 ; year:2023 ; pages:1-5 ; date:12.2023
npj vaccines ; 8, Heft 1 (20.11.2023), 1-5, 12.2023
- Creator
-
Ong, Chon Phin
Tang, Kaiming
Cheung, Pak-Hin Hinson
Zhang, Hongzhuo
Tang, Tze-Tung
Xue, Yaqian
Wang, Junjue
To, Kelvin Kai-Wang
Yuan, Shuofeng
Ye, Zi-Wei
Jin, Dong-Yan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00776-x
- URN
-
urn:nbn:de:101:1-2024020710311699433638
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
07.04.2025, 4:06 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ong, Chon Phin
- Tang, Kaiming
- Cheung, Pak-Hin Hinson
- Zhang, Hongzhuo
- Tang, Tze-Tung
- Xue, Yaqian
- Wang, Junjue
- To, Kelvin Kai-Wang
- Yuan, Shuofeng
- Ye, Zi-Wei
- Jin, Dong-Yan
- SpringerLink (Online service)
Other Objects (12)
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China